230 related articles for article (PubMed ID: 22887343)
1. Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer.
Algotar AM; Stratton MS; Ahmann FR; Ranger-Moore J; Nagle RB; Thompson PA; Slate E; Hsu CH; Dalkin BL; Sindhwani P; Holmes MA; Tuckey JA; Graham DL; Parnes HL; Clark LC; Stratton SP
Prostate; 2013 Feb; 73(3):328-35. PubMed ID: 22887343
[TBL] [Abstract][Full Text] [Related]
2. Oral selenium supplementation has no effect on prostate-specific antigen velocity in men undergoing active surveillance for localized prostate cancer.
Stratton MS; Algotar AM; Ranger-Moore J; Stratton SP; Slate EH; Hsu CH; Thompson PA; Clark LC; Ahmann FR
Cancer Prev Res (Phila); 2010 Aug; 3(8):1035-43. PubMed ID: 20647337
[TBL] [Abstract][Full Text] [Related]
3. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
Gontero P; Marra G; Soria F; Oderda M; Zitella A; Baratta F; Chiorino G; Gregnanin I; Daniele L; Cattel L; Frea B; Brusa P
Prostate; 2015 Aug; 75(11):1177-86. PubMed ID: 25893930
[TBL] [Abstract][Full Text] [Related]
4. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Klein EA; Thompson IM; Tangen CM; Crowley JJ; Lucia MS; Goodman PJ; Minasian LM; Ford LG; Parnes HL; Gaziano JM; Karp DD; Lieber MM; Walther PJ; Klotz L; Parsons JK; Chin JL; Darke AK; Lippman SM; Goodman GE; Meyskens FL; Baker LH
JAMA; 2011 Oct; 306(14):1549-56. PubMed ID: 21990298
[TBL] [Abstract][Full Text] [Related]
5. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial.
Duffield-Lillico AJ; Dalkin BL; Reid ME; Turnbull BW; Slate EH; Jacobs ET; Marshall JR; Clark LC;
BJU Int; 2003 May; 91(7):608-12. PubMed ID: 12699469
[TBL] [Abstract][Full Text] [Related]
6. Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study.
Stratton MS; Reid ME; Schwartzberg G; Minter FE; Monroe BK; Alberts DS; Marshall JR; Ahmann FR
Anticancer Drugs; 2003 Sep; 14(8):589-94. PubMed ID: 14501380
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial.
Meyer F; Galan P; Douville P; Bairati I; Kegle P; Bertrais S; Estaquio C; Hercberg S
Int J Cancer; 2005 Aug; 116(2):182-6. PubMed ID: 15800922
[TBL] [Abstract][Full Text] [Related]
8. Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the 'Watchful Waiting' Study.
Stratton MS; Reid ME; Schwartzberg G; Minter FE; Monroe BK; Alberts DS; Marshall JR; Ahmann FR
Anticancer Drugs; 2003 Sep; 14(8):595-600. PubMed ID: 14501381
[TBL] [Abstract][Full Text] [Related]
9. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Lippman SM; Klein EA; Goodman PJ; Lucia MS; Thompson IM; Ford LG; Parnes HL; Minasian LM; Gaziano JM; Hartline JA; Parsons JK; Bearden JD; Crawford ED; Goodman GE; Claudio J; Winquist E; Cook ED; Karp DD; Walther P; Lieber MM; Kristal AR; Darke AK; Arnold KB; Ganz PA; Santella RM; Albanes D; Taylor PR; Probstfield JL; Jagpal TJ; Crowley JJ; Meyskens FL; Baker LH; Coltman CA
JAMA; 2009 Jan; 301(1):39-51. PubMed ID: 19066370
[TBL] [Abstract][Full Text] [Related]
10. Selenium supplementation has no effect on serum glucose levels in men at high risk of prostate cancer.
Algotar AM; Hsu CH; Singh P; Stratton SP
J Diabetes; 2013 Dec; 5(4):465-70. PubMed ID: 23489776
[TBL] [Abstract][Full Text] [Related]
11. Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.
Marshall JR; Tangen CM; Sakr WA; Wood DP; Berry DL; Klein EA; Lippman SM; Parnes HL; Alberts DS; Jarrard DF; Lee WR; Gaziano JM; Crawford ED; Ely B; Ray M; Davis W; Minasian LM; Thompson IM
Cancer Prev Res (Phila); 2011 Nov; 4(11):1761-9. PubMed ID: 21896650
[TBL] [Abstract][Full Text] [Related]
12. A report of high-dose selenium supplementation: response and toxicities.
Reid ME; Stratton MS; Lillico AJ; Fakih M; Natarajan R; Clark LC; Marshall JR
J Trace Elem Med Biol; 2004; 18(1):69-74. PubMed ID: 15487766
[TBL] [Abstract][Full Text] [Related]
13. Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk.
Kristal AR; Darke AK; Morris JS; Tangen CM; Goodman PJ; Thompson IM; Meyskens FL; Goodman GE; Minasian LM; Parnes HL; Lippman SM; Klein EA
J Natl Cancer Inst; 2014 Mar; 106(3):djt456. PubMed ID: 24563519
[TBL] [Abstract][Full Text] [Related]
14. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial.
Duffield-Lillico AJ; Reid ME; Turnbull BW; Combs GF; Slate EH; Fischbach LA; Marshall JR; Clark LC
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):630-9. PubMed ID: 12101110
[TBL] [Abstract][Full Text] [Related]
15. No effect of selenium supplementation on serum glucose levels in men with prostate cancer.
Algotar AM; Stratton MS; Stratton SP; Hsu CH; Ahmann FR
Am J Med; 2010 Aug; 123(8):765-8. PubMed ID: 20670733
[TBL] [Abstract][Full Text] [Related]
16. Hemolysate thioredoxin reductase and glutathione peroxidase activities correlate with serum selenium in a group of New Zealand men at high prostate cancer risk.
Karunasinghe N; Ferguson LR; Tuckey J; Masters J
J Nutr; 2006 Aug; 136(8):2232-5. PubMed ID: 16857846
[TBL] [Abstract][Full Text] [Related]
17. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial.
Clark LC; Dalkin B; Krongrad A; Combs GF; Turnbull BW; Slate EH; Witherington R; Herlong JH; Janosko E; Carpenter D; Borosso C; Falk S; Rounder J
Br J Urol; 1998 May; 81(5):730-4. PubMed ID: 9634050
[TBL] [Abstract][Full Text] [Related]
18. Selenium supplementation and prostate cancer mortality.
Kenfield SA; Van Blarigan EL; DuPre N; Stampfer MJ; L Giovannucci E; Chan JM
J Natl Cancer Inst; 2015 Jan; 107(1):360. PubMed ID: 25505227
[TBL] [Abstract][Full Text] [Related]
19. Association between selenium and lycopene supplementation and incidence of prostate cancer: Results from the post-hoc analysis of the procomb trial.
Morgia G; Voce S; Palmieri F; Gentile M; Iapicca G; Giannantoni A; Blefari F; Carini M; Vespasiani G; Santelli G; Arnone S; Pareo RM; Russo GI
Phytomedicine; 2017 Oct; 34():1-5. PubMed ID: 28899491
[TBL] [Abstract][Full Text] [Related]
20. Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: Elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia.
Clark LC; Marshall JR
Urology; 2001 Apr; 57(4 Suppl 1):185-7. PubMed ID: 11295623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
